Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;101(4):1391-9.
doi: 10.1002/jps.23039. Epub 2011 Dec 28.

The role of adjuvant in mediating antigen structure and stability

Affiliations

The role of adjuvant in mediating antigen structure and stability

Latoya Jones Braun et al. J Pharm Sci. 2012 Apr.

Abstract

The purpose of this study was to probe the fate of a model antigen, a cysteine-free mutant of bacteriophage T4 lysozyme, to the level of fine structural detail, as a consequence of its interaction with an aluminum (Al)-containing adjuvant. Fluorescence spectroscopy and differential scanning calorimetry were used to compare the thermal stability of the protein in solution versus adsorbed onto an Al-containing adjuvant. Differences in accessible hydrophobic surface areas were investigated using an extrinsic fluorescence probe, 8-Anilino-1-naphthalenesulfonic acid (ANS). As has been observed with other model antigens, the apparent thermal stability of the protein decreased following adsorption onto the adjuvant. ANS spectra suggested that adsorption onto the adjuvant caused an increase in exposure of hydrophobic regions of the protein. Electrostatic interactions drove the adsorption, and disruption of these interactions with high ionic strength buffers facilitated the collection of two-dimensional (15) N heteronuclear single quantum coherence nuclear magnetic resonance data of protein released from the adjuvant. Although the altered stability of the adsorbed protein suggested changes to the protein's structure, the fine structure of the desorbed protein was nearly identical to the protein's structure in the adjuvant-free formulation. Thus, the adjuvant-induced changes to the protein that were responsible for the reduced thermal stability were not observed upon desorption.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Thermal unfolding based on intrinsic fluorescence data. Squares—T4 lysozyme in solution. Triangles—T4 lysozyme adsorbed onto adjuvant. The apparent Tms are approximately 64 ± 0.5°C and 43°C for the solution state and adsorbed protein, respectively. For comparison, the apparent Tms of these formulations according to DSC data (thermograms not shown) were 65 ± 0.5°C (solution state) and 45 ± 0.10°C (adsorbed).
Figure 2.
Figure 2.
Averaged emission spectra from ANS-binding experiments. Solid line—ANS in WT* T4 solution. Dashed line—ANS with adsorbed WT* T4 lysozyme. The spectra have been corrected by subtracting the appropriate blank spectrum: ANS in buffer, with or without adjuvant.
Figure 3.
Figure 3.
15N HSQC spectra of WT* T4 lysozyme in solution. (a) The spectrum of the protein in MOPS buffer containing 50mM NaCl in the absence of adjuvant. (b) The spectrum obtained in the same MOPS buffer containing 50mM NaCl in the presence of adjuvant. The reduction in signal intensity is due to the binding of protein to adjuvant. (c) The spectrum obtained in the presence of the same MOPS buffer in 200mM NaCl and adjuvant. Recovery of the signal is due to the desorption of protein from adjuvant. The spectrum suggests minimal perturbation to the protein as a result of binding.
Figure 4.
Figure 4.
Effect of increasing amounts of salt on adsorbed WT* T4 lysozyme. The graph shows the percentage of the previously adsorbed protein that is desorbed as when sodium chloride is added to the sample—determined by to UV–visible spectroscopy analysis of the supernatant.
Figure 5.
Figure 5.
(a) The effect of salt on the chemical shift values for residues in WT* T4 lysozyme. The graph shows the magnitude of the change in chemical shift due to salt (0 vs. 200mM) as a function of position in the protein in the absence of adjuvant. The inset shows a small region of the spectra containing the peaks for three residues (84, 105, and 144) at three salt concentrations 0mM NaCl (black), 100mM NaCl (cyan), and 200mM NaCl (red) in MOPS buffer. (b) Chemical shift changes of desorbed WT* T4 lysozyme in the presence of adjuvant relative to the adjuvant-free solution state sample in the presence of identical concentrations of NaCl. Red—100mM NaCl. Orange—150mM NaCl. Yellow—200mM NaCl. The inset shows a small region of the 15N HSQC spectrum of the protein as in panel (a) in the presence of 200mM NaCl with adjuvant (black) and without adjuvant (red).
Figure 6.
Figure 6.
The adjuvant-dependent differences in chemical shifts at 100mM NaCl mapped onto the structure of the protein. Residues with the largest chemical shift changes (0.04–0.06 ppm) are shown in red and residues with moderate changes (0.025–0.04 ppm) are shown in yellow. The figure was generated using Pymol (The PyMOL Molecular Graphics System, version 1.2r3pre; Schrödinger, LLC (Portland, Oregon) using the PDB file 1L63.

Similar articles

Cited by

References

    1. Ausar SF, Chan J, Hoque W, James O, Jayasundara K, Harper K. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminumadjuvanted vaccines. J Pharm Sci 100(2):431–440. - PubMed
    1. Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. 2005. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem 280(14):13406–13414. - PubMed
    1. Peek LJ, Martin TT, Elk Nation C, Pegram SA, Middaugh CR.2007. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants. J Pharm Sci 96(3):547–557. - PubMed
    1. Vessely C, Estey T, Randolph TW, Henderson I, Cooper J,Nayar R, Braun LJ, Carpenter JF. 2009. Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution. J Pharm Sci 98(9):2970–2993. - PMC - PubMed
    1. Matsumura M, Matthews BW. 1989. Control of enzyme activity by an engineered disulfide bond. Science 243(4892):792–794. - PubMed

Publication types

MeSH terms